Clinical Trial

Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia

Name: Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With Hypercholesterolemia — clinical trial record (NCT07445542)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

A Multi-center, Open-label, Observational Study to evaluate the Efficacy and Safety of Pitavastatin/Ezetimibe after switching from Statin Monotherapy to Pitavastatin/Ezetimibe in patients with Hypercholesterolemia

Trial Details

NCT Number	NCT07445542
Lead Sponsor	JW Pharmaceutical
Conditions	Hypercholesterolemia
Enrollment	6,927 participants
Start Date	2021-12-18
Primary Completion	2025-05-13 (estimated)
Study Completion	2025-05-13 (estimated)
Updated on ClinicalTrials.gov	2026-03-03